Markets.com Logo

OPGX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.0002$
  • Previous Close
    0.0002$
  • 52 Week Change
    0.00$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.0003$ - 0.0003$
  • Dividend Per Share
    --
  • Market cap
    6 648$
  • EPS
    -3.5556
  • Beta
    -1.001
  • Volume
    --

About

OPGX.US represents shares of OptiNose, Inc., a pharmaceutical company focused on developing and commercializing products for patients managed by ear, nose, and throat (ENT) and allergy specialists. Their key product is XHANCE, a nasal spray for the treatment of chronic rhinosinusitis with nasal polyps. The company also has a pipeline of other potential products addressing related conditions. Investors in OPGX.US are essentially investing in the future success of OptiNose's existing products and its ability to develop and commercialize new therapies.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Company Performance: OPGX's revenue, profit margins, and earnings reports heavily influence investor confidence and thus the stock price.

Industry Trends: The overall health and growth prospects of the pharmaceutical industry and particularly opioid addiction treatment impacts OPGX.US.

Regulatory Environment: Changes in laws, regulations, and FDA approvals related to opioid addiction treatments significantly affect OPGX's valuation.

Market Sentiment: General investor optimism or pessimism about the stock market can indirectly impact OPGX's stock price.

Competition: The presence and performance of competing pharmaceutical companies in the addiction treatment space influence OPGX's market share and stock price.

Clinical Trial Results: Outcomes of clinical trials for new or existing treatments influence the perception of OPGX's potential and its stock valuation.

Economic Conditions: Broad economic factors such as interest rates and inflation can impact investment decisions and affect OPGX's stock price.

News and Events: Major news announcements related to the company, such as partnerships or acquisitions, can cause fluctuations in stock price.

Management Decisions: Strategic decisions made by OPGX's leadership team, such as investments or restructuring, influence investor confidence.

Analyst Ratings: Recommendations and price targets issued by financial analysts can impact investor sentiment and the stock's valuation.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--